98%
921
2 minutes
20
Many patients with chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS) also experience depression, although the pathogenesis was unclear. Some studies have shown that gut microbiota disorder might be related to both prostatitis and depression. Therefore, we investigated the alteration of the gut microbiota in autoimmune CP/CPPS complicated with depression in a rat model. The rat model of autoimmune CP with comorbid depressive-like behavior was constructed by experimental autoimmune prostatitis (EAP) and chronic unpredictable mild stress (CUMS). Then, enzyme linked immunosorbent assay (ELISA) was performed to determine the concentration of inflammatory cytokines. The depression-like behaviors in rats were also detected using the open field test (OFT), forced swimming test (FST), and sucrose preference test (SPT). The composition of the gut microbiota and the microbial profile in rats were measured by bioinformatics analysis of the 16S rRNA gene sequence. The level of interleukin (IL)-1β, IL-6, tumor necrosis factor α (TNF-α), and depression-like behavior in rats showed that the CP/CPPS complicated with depression model was established successfully. The results of the 16S rRNA sequence analysis showed disordered abundance, uniformity, and composition of gut microbiota in EAP + CUMS rats. Over 60 gut microbial metabolic pathways were predicted to be disordered among the four groups of rats. Additionally, metabolomics profiling indicated significant differences in EAP + CUMS rats compared to other groups, including reduced PWY-922, PWY-5198 and PWY-7159, and increased PWY0-321 and PWY-6629, which were predicted to be altered by Lactobacillus, Shigella, Blautia, Clostridiales, Comamonadaceae and Rhodospirillales. Our results have shown that gut microbiota disorders are associated with depressive-like behavior in experimental prostatitis. Our findings concerning gut microbiota provide new insights in understanding prostatitis-associated depression.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12010-025-05294-1 | DOI Listing |
Folia Microbiol (Praha)
September 2025
Department of Gastroenterology, Chongqing University Cancer Hospital, Chongqing, China.
Microbiome dysbiosis in reflux esophagitis has been extensively studied. However, limited research has examined microbiota across different segments of the upper gastrointestinal tract in reflux esophagitis. In this study, we investigated microbial alterations in three esophageal segments (upper, middle, and lower) and the gastric fundus of reflux esophagitis patients and healthy controls.
View Article and Find Full Text PDFNat Cancer
September 2025
Nature Cancer, .
J Immunother Cancer
September 2025
National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Background: Improving the efficacy of anti-programmed death 1 (PD-1) monoclonal antibody (mAb) therapy remains a major challenge for cancer immunotherapy in non-small cell lung cancer (NSCLC). Gut microbial metabolites can influence immunotherapy efficacy.
Methods: ELISA was used to compare the serum 5-hydroxyindoleacetic acid (5-HIAA) level in patients with NSCLC.
BMJ Open
September 2025
Department of Gastroenterology, Hepatology, Infectious Diseases and Intoxication, University Hospital Heidelberg, Heidelberg, Germany.
Introduction: Combined vascular endothelial growth factor/programmed death-ligand 1 blockade through atezolizumab/bevacizumab (A/B) is the current standard of care in advanced hepatocellular carcinoma (HCC). A/B substantially improved objective response rates compared with tyrosine kinase inhibitor sorafenib; however, a majority of patients will still not respond to A/B. Strong scientific rationale and emerging clinical data suggest that faecal microbiota transfer (FMT) may improve antitumour immune response on PD-(L)1 blockade.
View Article and Find Full Text PDFMicrob Pathog
September 2025
Department of Chinese Formulae, Heilongjiang University of Chinese Medicine, Harbin, China. Electronic address:
Sepsis is a systemic inflammatory response syndrome triggered by infection. Severe sepsis is associated with dysbiosis of the intestinal flora and impaired intestinal function. Ellagic acid (EA) is a natural compound known for its ability to inhibit bacteria and viruses, thereby preventing infections.
View Article and Find Full Text PDF